sepsi
death
infect
given
preval
cap
potenti
caus
sever
ill
emerg
provid
must
thorough
understand
multifacet
condit
abl
take
nuanc
approach
manag
emerg
physician
need
recogn
symptom
suggest
cap
order
appropri
diagnost
test
select
recommend
empir
antibiot
risk
stratifi
patient
proper
disposit
articl
provid
overview
cap
adult
touch
drugresist
health
careassoci
diseas
opportunist
lung
infect
tuberculosi
hospitalacquir
pneumonia
beyond
scope
review
etiolog
antibiot
resist
pattern
respiratori
pathogen
vari
geograph
region
evolv
time
develop
vaccin
major
case
requir
hospit
pathogen
identifi
us
populationbas
surveil
studi
patient
admit
cap
patient
pathogen
identifi
viral
bacteri
pathogen
could
isol
patient
common
pathogen
rhinoviru
follow
influenza
viru
streptococcu
pneumonia
mycoplasma
pneumonia
staphylococcu
aureu
second
third
common
bacteri
pathogen
respect
bacteri
speci
commonli
caus
cap
includ
legionella
pneumophila
haemophilu
influenza
chlamydophila
pneumonia
moraxella
catarrhali
common
viral
caus
includ
human
rhinoviru
influenza
also
human
metapneumoviru
parainfluenza
viru
respiratori
syncyti
viru
coronaviru
adenoviru
middl
east
respiratori
syndrom
coronaviru
peak
influenza
season
influenza
may
common
caus
cap
requir
hospit
although
often
complic
secondari
bacteri
infect
fungal
etiolog
gener
rare
immunocompet
host
coccidioidomycosi
rel
common
caus
pneumonia
pneumon
western
unit
state
mimic
bacteri
pneumonia
geograph
endem
mycos
includ
histoplasma
capsulatum
blastomyc
ohio
mississippi
river
valley
opportunist
fungal
pneumonia
frequent
seen
patient
aid
solid
organ
transplant
includ
pneumocyst
jiroveci
pneumonia
aspergillu
candida
albican
cryptococcu
neoforman
tabl
categor
pneumonia
evolv
recent
pneumonia
divid
categori
cap
health
careassoci
pneumonia
hcap
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
outsid
scope
articl
hcap
categori
includ
patient
regular
contact
health
care
system
includ
nurs
home
resid
patient
undergo
home
infus
therapi
wound
care
dialysi
patient
patient
hospit
day
prior
day
patient
thought
higher
risk
pneumonia
caus
multidrugresist
mdr
bacteria
warrant
broad
spectrum
antibiot
coverag
similar
hospitalacquir
pneumonia
common
mdr
pathogen
includ
pseudomona
aeruginosa
methicillinresist
aureu
mrsa
gramneg
enterobacteriacea
speci
topic
current
flux
hcap
criteria
neither
sensit
specif
identifi
patient
infect
mdr
organ
treat
patient
regimen
hospitalacquir
pneumonia
lead
overtreat
broad
spectrum
antibiot
excess
mortal
hcap
may
larg
attribut
patient
comorbid
rather
drugresist
pathogen
infecti
diseas
societi
america
idsa
american
thorac
societi
remov
hcap
categori
guidelin
forthcom
guidelin
recommend
group
formal
known
hcap
divid
group
appropri
limit
spectrum
therapi
risk
factor
mdr
requir
broad
spectrum
therapi
tabl
list
risk
factor
import
mdr
organ
although
evid
topic
remain
incomplet
exact
recommend
yet
clear
remain
import
identifi
ed
patient
requir
broad
spectrum
empir
antibiot
histor
penicillin
suffici
treatment
pneumonia
past
decad
preval
drug
resist
pneumococcu
increas
alter
penicillinbind
protein
main
resist
mechan
unit
state
pneumonia
owe
penicillin
nonsuscept
strain
increas
clinic
signific
penicillinresist
pneumonia
remain
unclear
mix
data
mortal
impact
associ
cost
durat
stay
howev
advers
outcom
associ
highlevel
penicillin
resist
minimum
inhibitori
concentr
infect
requir
treatment
cephalosporin
fluoroquinolon
macrolideresist
pneumococcu
also
grow
problem
mechan
highlevel
resist
involv
methyl
ribosom
bind
site
wherea
lower
level
resist
involv
drug
efflux
via
membran
transport
studi
conduct
japan
macrolideresist
strain
exceed
area
found
rider
fraze
patient
still
good
clinic
respons
azithromycin
suggest
clinic
signific
resist
unclear
vivo
unit
state
macrolideresist
pneumococcu
averag
greatest
preval
louisiana
statebyst
variat
high
macrolid
resist
consid
highresist
region
particularli
recent
antibiot
exposur
macrolid
monotherapi
consid
macrolideresist
pneumonia
emerg
around
anoth
concern
drugresist
cap
pathogen
resist
confer
point
mutat
macrolid
bind
ribosom
subunit
studi
center
throughout
unit
state
reveal
pneumonia
macrolid
resist
rate
pneumonia
alveolar
infect
occur
innat
immun
system
unabl
clear
pathogen
lower
airway
alveoli
local
inflammatori
factor
cytokin
caus
addit
harm
lung
parenchyma
lead
system
inflamm
caus
secondari
symptom
fever
chill
fatigu
histolog
level
inflammatori
respons
caus
congest
progress
red
gray
hepat
may
resolv
minim
fibrosi
term
lung
mechan
physiolog
pu
parenchyma
lead
decreas
complianc
shunt
increas
work
breath
worsen
hypoxemia
tachypneath
import
physic
examin
sign
sever
pneumonia
emerg
physician
focu
bedsid
cap
affect
patient
age
across
spectrum
health
certain
organ
predilect
specif
patient
subgroup
condit
caus
decreas
mucociliari
clearanc
cough
like
cigarett
smoke
put
patient
increas
risk
condit
lead
aspir
cerebr
vascular
accid
esophag
disord
neuromuscular
disord
old
age
dehydr
affect
pneumonia
manifest
make
recognit
difficult
underli
cardiopulmonari
diseas
structur
lung
diseas
also
delay
recognit
epidemiolog
pneumonia
carri
highest
mortal
infecti
diseas
lower
respiratori
tract
infect
common
infecti
caus
death
world
million
death
annual
worldwid
world
health
organ
unit
state
influenza
pneumonia
list
togeth
lead
caus
death
highest
rate
among
elderli
adult
age
year
outcom
patient
requir
hospit
pneumonia
poor
mortal
readmiss
rate
interestingli
mortal
cap
hospit
remain
increas
year
year
patient
chronic
obstruct
pulmonari
diseas
diabet
mellitu
renal
failur
congest
heart
failur
coronari
arteri
diseas
liver
diseas
increas
incid
cap
fortun
use
pneumococc
conjug
vaccin
may
respons
decreas
incid
pneumonia
daytoday
practic
main
differenti
diagnosi
immunocompet
ambulatori
patient
present
acut
cough
ill
cap
versu
viral
bronchiti
correctli
distinguish
two
depend
larg
part
element
communityacquir
pneumonia
histori
physic
examin
particularli
age
upper
respiratori
infect
symptom
puls
oximetri
lung
sound
em
practic
chest
radiograph
also
play
central
role
cap
distinguish
presenc
alveolar
infiltr
chest
radiograph
wherea
bronchiti
normal
chest
radiograph
possibl
except
peribronchi
thicken
accur
distinguish
pneumonia
acut
bronchiti
one
import
way
emerg
physician
improv
antibiot
stewardship
case
acut
cough
neg
radiograph
possibl
diagnos
includ
viral
bronchiti
asthma
gastroesophag
reflux
diseas
postnas
drip
sinus
medic
side
effect
particularli
angiotensinconvert
enzym
inhibitorinduc
cough
tabl
infiltr
present
radiograph
import
noninfecti
caus
consid
includ
pulmonari
edema
pulmonari
embol
pulmonari
infarct
lung
cancer
alveolar
hemorrhag
arterioven
malform
goodpastur
syndrom
wegen
granulomatosi
bronchiectasi
cryptogen
organ
pneumonia
acut
eosinophil
pneumonia
interstiti
lung
diseas
vascul
cocaineinduc
lung
injuri
pulmonari
contus
drug
reaction
high
altitud
pulmonari
edema
among
other
chest
radiograph
abnorm
addit
common
bacteri
viral
infecti
etiolog
emerg
physician
need
keep
mind
less
common
infecti
caus
pneumonia
immunocompet
host
may
develop
infect
endem
mycos
histoplasmosi
blastomycosi
coccidiomycosi
septic
emboli
consid
patient
multipl
site
infect
histori
inject
drug
use
immunocompromis
host
particularli
patient
infect
human
immunodefici
viru
hiv
risk
opportunist
lung
infect
includ
fungal
pathogen
p
jiroveci
p
jiroveci
pneumonia
aspergillu
c
albican
mucormycosi
c
neoforman
well
mycobacterium
tabl
differenti
diagnosi
noninfecti
caus
infiltr
chest
radiograph
differenti
diagnosi
caus
normal
chest
radiograph
set
acut
cough
ill
abnorm
chest
radiograph
infecti
refer
micro
tuberculosi
mycobacterium
avium
complex
tuberculosi
p
jiroveci
pneumonia
remark
common
easili
misdiagnos
caus
pneumonia
hivinfect
patient
count
less
cellsmm
evalu
pneumonia
emerg
physician
consid
possibl
patient
hiv
otherwis
immunocompromis
although
diagnost
criteria
cap
seem
rel
straightforward
make
correct
diagnosi
difficult
thought
histori
physic
examin
close
attent
actual
respiratori
rate
core
temperatur
well
care
interpret
chest
radiograph
requir
caution
especi
true
elderli
clinic
diagnosi
cap
made
basi
respiratori
symptom
cough
sputum
product
dyspnea
chest
pain
sign
fever
hypoxemia
well
infiltr
chest
imag
addit
symptom
may
includ
myalgia
fatigu
abdomin
pain
headach
make
cap
difficult
distinguish
viral
infect
particularli
influenza
base
histori
alon
possibl
chest
examin
find
includ
dull
percuss
decreas
breath
sound
inspiratori
crackl
patient
ambulatori
set
symptom
suggest
respiratori
infect
preval
pneumonia
possibl
rule
cap
without
chest
radiograph
nonelderli
patient
without
abnorm
vital
sign
without
focal
abnorm
auscultatori
examin
probabl
cap
abnorm
chest
radiograph
less
rule
cap
without
radiograph
attempt
howev
elderli
patient
mani
mount
typic
sign
symptom
mani
elderli
patient
cap
afebril
ed
preexist
oxygen
problem
lung
diseas
complic
pictur
fig
outlin
simplifi
diagnost
approach
ambulatori
patient
cough
suspicion
cap
patient
elderli
normal
vital
sign
normal
auscultatori
examin
gener
given
diagnosi
bronchiti
discharg
home
without
antibiot
vital
sign
examin
abnorm
fig
summari
diagnost
approach
acut
cough
ill
ambulatori
patient
show
central
role
chest
radiograph
case
communityacquir
pneumonia
cap
sever
assess
typic
clinic
decis
rule
abnl
abnorm
abx
antibiot
ausc
auscult
cx
cultur
cxr
chest
radiograph
icu
intens
care
unit
inpt
inpati
iv
intraven
outpt
outpati
tx
treatment
vs
vital
sign
patient
elderli
chest
radiograph
obtain
film
normal
correct
diagnosi
usual
bronchiti
rare
earli
diseas
cours
sever
dehydr
patient
chest
radiograph
normal
cap
uncommon
issu
ambulatori
patient
less
year
old
chest
radiograph
confirm
diagnosi
cap
next
step
risk
stratif
see
sever
assess
clinic
decis
rule
mani
patient
determin
low
risk
mortal
clinic
decis
rule
diagnost
test
requir
discharg
import
remain
step
patient
proper
oral
antibiot
select
see
fig
chest
radiograph
crucial
diagnost
test
cap
adult
physic
examin
alon
less
sensit
specif
chest
radiograph
infiltr
may
subtl
studi
includ
posteroanterior
later
view
prefer
opac
typic
develop
within
hour
common
find
includ
peribronchi
nodul
silhouett
sign
parapneumon
effus
ground
glass
opac
sever
pneumonia
character
multilobar
involv
cavit
bilater
pleural
effus
howev
radiograph
appear
necessarili
correspond
clinic
sever
infiltr
may
evolv
independ
clinic
improv
worsen
although
etiolog
reliabl
predict
chest
radiograph
appear
follow
classic
associ
radiograph
find
etiolog
describ
literatur
pneumonia
typic
appear
alveolar
lobar
pneumonia
lower
lobe
multilobar
involv
frequent
seen
bilater
diseas
interstiti
infiltr
found
case
mycoplasma
typic
produc
reticulonodular
opac
patchi
consolid
mycoplasma
target
bronchial
epithelium
therefor
caus
bronchial
wall
thicken
peribronchi
cuf
central
bronchi
like
respiratori
virus
similarli
chlamydia
pneumonia
classic
show
patchi
consolid
reticular
opac
viral
pneumonitispneumonia
radiograph
indistinguish
bacteri
cap
ground
glass
opac
common
find
normal
chest
radiograph
final
aspir
pneumonia
commonli
affect
posterior
inferior
segment
lung
may
cavit
subacut
chronic
interpret
chest
radiograph
howev
imperfect
practic
radiograph
pattern
poorli
predict
etiolog
radiologist
may
miss
infiltr
case
time
cap
present
may
also
affect
radiograph
appear
chest
radiograph
may
seem
normal
first
hour
pneumonia
patient
hiv
earli
p
jirovecii
infect
set
sever
dehydr
common
patient
skill
nurs
facil
case
clinic
diagnosi
pneumonia
consid
even
chest
radiograph
seem
normal
reason
treat
pneumonia
repeat
radiograph
day
comput
tomographi
ct
sensit
plain
radiograph
detect
pneumonia
although
clinic
signific
infiltr
seen
ct
chest
radiograph
debat
recent
prospect
surveil
studi
show
ill
sever
pathogen
clinic
outcom
compar
patient
cap
abnorm
chest
radiograph
diagnos
ct
scan
without
obviou
infiltr
radiograph
clinic
suspicion
pneumonia
remain
high
despit
neg
chest
radiograph
advanc
imag
consid
empir
treatment
initi
ct
scan
may
better
visual
certain
area
lung
upper
lobe
lingula
elucid
interstiti
infiltr
seen
atyp
pathogen
ct
scan
use
character
necrot
infect
multilobar
diseas
empyema
pleural
involv
also
help
differenti
cap
tuberculosi
lung
cancer
difficult
distinguish
chest
radiograph
alon
guidelin
support
use
ultrasound
examin
diagnosi
pneumonia
adult
imag
modal
avail
howev
metaanalysi
conclud
hand
experienc
oper
ultrasound
examin
may
sensit
specif
high
respect
ultrasound
examin
may
offer
ideal
altern
diagnost
modal
pediatr
patient
critic
ill
patient
difficult
obtain
film
fig
histori
physic
examin
imag
studi
confirm
diagnosi
cap
addit
etiolog
test
may
may
requir
depend
patient
clinic
statu
disposit
area
hold
consider
controversi
emerg
medicin
identif
caus
organ
use
resourc
costli
even
reveal
pathogen
etiolog
test
rare
lead
chang
treatment
contrast
case
organ
identifi
may
allow
deescal
broad
narrow
spectrum
treatment
hospit
therebi
decreas
cost
care
prevent
advers
effect
etiolog
test
also
import
public
health
standpoint
allow
epidemiolog
monitor
drug
suscept
incid
specif
pathogen
idsa
recommend
direct
test
toward
patient
highest
expect
yield
outpati
etiolog
test
except
rapid
diagnost
test
influenza
rare
indic
obtain
antibiot
administr
blood
cultur
grow
pathogen
cap
case
depend
diseas
sever
sensit
blood
cultur
halv
antibiot
alreadi
administ
common
isol
pneumonia
although
pneumococc
infect
rare
requir
chang
therapi
base
isol
suscept
isol
allow
surveil
penicillin
macrolid
resist
among
hospit
patient
blood
cultur
alway
drawn
sever
cap
requir
admiss
intens
care
unit
icu
patient
admit
floor
blood
cultur
option
perform
patient
alcohol
abus
liver
diseas
leukopenia
effus
asplenia
patient
sever
cap
also
respiratori
specimen
obtain
cultur
gram
stain
sputum
obtain
within
hour
initi
antibiot
yield
respiratori
cultur
significantli
higher
endotrach
aspir
bronchoscop
sampl
sent
intub
patient
cap
absenc
aureu
gramneg
rod
respiratori
specimen
suggest
pathogen
caus
ill
allow
antibiot
regimen
narrow
earli
hospit
although
use
polymeras
chain
reaction
increas
detect
viral
respiratori
pathogen
cap
role
test
influenza
remain
unclear
influenza
test
recommend
admit
patient
local
influenza
activ
high
also
recommend
patient
sever
cap
urinari
antigen
test
pneumonia
well
legionella
pneumophilia
legionella
serogroup
suspect
pneumonia
urinari
antigen
test
remain
posit
day
initi
therapi
local
health
depart
notif
requir
legionella
detect
may
indic
outbreak
gener
etiolog
test
done
patient
histori
alcohol
abus
liver
diseas
lung
diseas
leukopenia
cavitari
infiltr
asplenia
pleural
effus
recent
travel
serum
lactat
wide
recommend
screen
test
sever
sepsi
elev
set
infect
lactat
level
independ
predict
mortal
prospect
observ
studi
compar
serum
lactat
patient
cap
show
lactat
better
predict
mortal
hospit
icu
admiss
lactat
routin
drawn
along
blood
cultur
part
workup
patient
hospit
sever
cap
help
guid
resuscit
treatment
disposit
test
acut
phase
reactant
grow
role
evalu
cap
infecti
diseas
particularli
pediatr
popul
procalcitonin
acut
phase
reactant
low
circul
level
ngml
normal
increas
inflammatori
diseas
particularli
respons
bacteri
toxin
procalcitonin
level
may
help
distinguish
bacteri
viral
infect
although
data
consist
procalcitonin
may
also
serv
marker
diseas
sever
low
decreas
may
allow
deescal
termin
antibiot
inpati
set
metaanalysi
random
trial
use
procalcitonin
associ
decreas
durat
antibiot
therapi
day
without
chang
mortal
anoth
metaanalysi
show
lower
mortal
among
critic
ill
patient
allow
procalcitoninguid
cessat
antibiot
biomark
current
investig
differenti
viral
bacteri
ill
includ
creactiv
protein
cortisol
although
biomark
may
futur
role
riskstratif
cap
ed
set
ed
studi
limit
time
fig
owe
wide
spectrum
diseas
sever
cap
strongli
recommend
emerg
physician
routin
use
structur
clinic
decis
rule
risk
stratifi
patient
cap
number
rule
develop
valid
use
determin
intens
diagnost
test
optim
safe
disposit
patientto
home
inpati
ward
inpati
icu
besid
help
identifi
sickest
subset
patient
anoth
import
benefit
clinic
decis
rule
promot
safe
discharg
lowrisk
patient
might
otherwis
admit
hospit
unnecessarili
idsa
divid
sign
sever
cap
major
minor
criteria
approxim
patient
hospit
cap
requir
icu
stay
absolut
crucial
emerg
physician
recogn
sign
sever
diseas
ensur
appropri
disposit
minor
criteria
includ
respiratori
rate
greater
breath
per
minut
pao
fio
less
multilobar
infiltr
confus
uremia
leukopenia
thrombocytopenia
hypothermia
hypotens
clinic
less
help
major
criteria
mechan
ventil
septic
shock
requir
vasopressor
icu
admiss
recommend
major
criteria
minor
criteria
minor
sign
repres
valuabl
guid
identifi
subtl
organ
system
dysfunct
hypoperfus
care
assess
subtl
sign
poor
organ
perfus
key
effect
care
patient
cap
critic
earli
intervent
includ
prompt
antibiot
treatment
monitor
serial
blood
gase
serum
lactat
level
frequent
reassess
wide
valid
use
cap
clinic
decis
rule
pneumonia
sever
index
psi
psi
develop
pneumonia
patient
outcom
research
team
effort
predict
shortterm
cap
mortal
tabl
intend
immunocompet
adult
base
data
avail
present
higher
score
higher
risk
death
eventu
admiss
icu
practic
score
help
emerg
provid
determin
appropri
disposit
destin
psi
class
iv
v
patient
hospit
class
v
usual
requir
icu
admiss
class
iii
patient
may
appropri
observ
dose
intraven
antibiot
hydrat
class
ii
patient
usual
safe
manag
outpati
psi
extern
valid
sever
larg
trial
random
control
trial
hospit
confirm
use
safe
reduc
low
risk
admiss
abbrevi
bp
blood
pressur
bun
blood
urea
nitrogen
dbp
diastol
blood
pressur
hr
heart
rate
icu
intens
care
unit
rr
respiratori
rate
sbp
systol
blood
pressur
score
combin
variabl
determin
diseas
sever
place
emphasi
physiolog
paramet
much
easier
calcul
psi
see
tabl
one
point
assign
confus
blood
urea
nitrogen
mgdl
greater
respiratori
rate
greater
blood
pressur
less
mm
hg
diastol
mm
hg
greater
age
greater
patient
score
higher
admit
hospit
wellvalid
psi
measur
compar
psi
variabl
boast
slightli
higher
discriminatori
power
mortal
classifi
slightli
higher
percentag
patient
low
risk
sens
greater
use
pneumonia
clinic
decis
rule
lesswid
use
unit
state
includ
smartcop
adrop
cappiro
australian
smartcop
score
assign
point
low
systol
blood
pressur
multilobar
infiltr
low
albumin
tachypnea
tachycardia
confus
hypoxemia
acidemia
score
point
identifi
patient
would
later
receiv
vasopressor
ventil
support
adrop
score
system
develop
japanes
respiratori
societi
use
variabl
age
male
femal
dehydr
blood
urea
nitrogen
mgml
respiratori
failur
sao
confus
hypotens
similar
clinic
decis
rule
surpris
seem
emerg
prefer
score
ed
simplic
although
psi
still
role
better
identifi
patient
seem
fenc
actual
safe
discharg
addit
clinic
decis
rule
assess
nonmeasur
factor
import
determin
disposit
patient
discharg
emerg
physician
must
consid
likelihood
direct
complic
pneumonia
hypoxemia
pleural
effus
exacerb
underli
diseas
patient
abil
take
oral
medic
avail
caregiv
discharg
appropri
respiratori
rate
less
breath
per
minut
satur
peripher
oxygen
greater
mental
statu
normal
patient
toler
oral
intak
final
psychosoci
factor
patient
prefer
must
consid
outpati
care
cap
cost
time
less
hospit
patient
resum
normal
activ
faster
provid
encourag
discharg
deem
clinic
social
safe
treatment
antibiot
therapi
cap
direct
common
pathogen
consider
local
resist
pattern
patient
disposit
diagnosi
made
antibiot
administ
soon
possibl
longer
cm
qualiti
metric
regard
time
treatment
wide
accept
target
within
hour
present
patient
exhibit
sign
sepsi
receiv
antibiot
within
hour
avail
local
empir
antibiot
treatment
guidelin
reflect
hospit
antibiogram
follow
nonsever
case
goal
reliabl
cover
pneumonia
atyp
bacteri
pathogen
decis
provid
broader
coverag
base
health
care
exposur
risk
factur
histori
structur
lung
diseas
specif
condit
eg
known
mrsa
colon
outpati
without
coexist
ill
recent
antibiot
use
idsa
recommend
macrolid
azithromycin
clarithromycin
doxycyclin
coexist
ill
present
patient
recent
use
antibiot
respiratori
fluoroquinolon
moxifloxacin
levofloxacin
recommend
betalactam
eg
amoxicillin
plu
communityacquir
pneumonia
macrolid
may
also
use
risk
factor
drugresist
streptococcu
pneumonia
includ
comorbid
heart
diseas
liver
diseas
renal
diseas
diabet
alcohol
immunosuppress
antimicrobi
use
within
previou
month
see
tabl
patient
respiratori
fluoroquinolon
prescrib
betalactam
plu
macrolid
cohort
patient
treat
cap
ed
approxim
onehalf
risk
factor
drugresist
pneumonia
rais
concern
potenti
overus
fluoroquinolon
area
louisiana
larg
percentag
macrolideresist
pneumonia
defin
minimum
inhibitori
concentr
respiratori
fluoroquinolon
betalactam
plu
macrolid
use
see
tabl
treatment
guidelin
hospit
patient
idsa
guidelin
recommend
betalactam
plu
macrolid
eg
ceftriaxon
plu
azithromycin
increas
evid
patient
better
combin
antibiot
rather
fluoroquinolon
monotherapi
possibl
relat
immunomodul
high
local
influenza
activ
hospit
patient
gener
also
treat
oseltamivir
droplet
contact
precaut
use
influenza
suspect
risk
mdr
pathogen
must
consid
select
treatment
regimen
hospit
patient
see
tabl
mdr
risk
factor
medic
comorbid
recent
hospit
recent
antibiot
immunosuppress
coverag
p
aeruginosa
recommend
pseudomona
invari
mdr
may
caus
sever
cap
case
associ
case
fatal
rate
cover
mdr
organ
antipseudomon
cephalosporin
eg
cefepim
ceftazidim
carbapenem
eg
meropenem
imipenem
antipseudomon
penicillin
eg
piperacillintazobactam
plu
antipseudomon
fluoroquinolon
recommend
mrsa
coverag
vancomycin
linezolid
ad
patient
suspect
recent
coinfect
influenza
chronic
glucocorticoid
use
risk
factor
mrsa
see
tabl
recommend
durat
cap
therapi
day
evid
suggest
differ
outcom
treatment
durat
day
less
compar
day
except
includ
aureu
lobar
pneumonia
may
requir
extend
treatment
week
aureu
bacteremia
gener
requir
week
intraven
treatment
atyp
infect
also
except
pneumonia
c
pneumonia
known
caus
organ
day
recommend
legionella
day
therapi
recommend
hospit
patient
earli
switch
intraven
oral
antibiot
compromis
outcom
decreas
durat
stay
addit
antimicrobi
symptomat
care
cap
treatment
adjunct
consid
corticosteroid
import
wide
debat
steroid
may
attenu
inflammatori
respons
reduc
frequenc
acut
respiratori
distress
syndrom
decreas
length
ill
systemat
review
metaanalysi
suggest
steroid
reduc
need
mechan
ventil
rate
acut
respiratori
distress
syndrom
estim
number
need
treat
despit
evid
favor
steroid
mani
highqual
studi
show
benefit
case
adjunct
steroid
stronger
sever
cap
steroid
trial
patient
vasopressordepend
shock
select
patient
sever
cap
evid
inadequ
cortisol
respons
earli
physic
therapi
anoth
import
treatment
adjunct
hospit
patient
singlecent
retrospect
studi
show
associ
physic
therapi
minut
lower
readmiss
rate
discharg
patient
inform
usual
cours
ill
cap
previous
healthi
adult
pneumococc
pneumonia
fever
typic
resolv
within
day
initi
antibiot
one
week
present
patient
still
fatigu
dyspnea
overal
patient
improv
clinic
much
faster
radiograph
clear
patient
hospit
cap
mortal
rate
time
greater
control
mortal
remain
elev
year
even
patient
comorbid
excess
cardiovascular
risk
observ
year
infect
phenomenon
like
due
fact
system
inflamm
destabil
coronari
plaqu
produc
procoagul
effect
primari
care
provid
ensur
pneumonia
diagnosi
patient
receiv
aspirin
statin
elig
primari
care
set
import
measur
reduc
patient
risk
cap
encourag
smoke
cessat
tobacco
use
interfer
immun
system
lung
function
children
vaccin
pneumonia
h
influenza
hib
healthi
adult
age
receiv
vaccin
pneumonia
given
adult
older
previous
receiv
dose
given
least
year
later
regimen
especi
import
patient
chronic
obstruct
pulmonari
diseas
pneumococc
vaccin
shown
reduc
likelihood
cap
need
treat
exacerb
chronic
obstruct
pulmonari
diseas
influenza
vaccin
given
yearli
elig
patient
final
frequent
hand
wash
encourag
patient
provid
alik
primarili
prevent
spread
respiratori
virus
histori
physic
examin
includ
vital
sign
satur
peripher
oxygen
chest
radiograph
result
provid
essenti
inform
clinic
diagnos
cap
cap
caus
bacteri
viral
pathogen
essenti
queri
patient
past
medic
histori
risk
factor
predispos
drugresist
pneumonia
concept
hcap
chang
ed
provid
need
awar
risk
factor
mdr
pneumonia
limit
broad
spectrum
antibiot
patient
satisfi
guidelinerecommend
criteria
sever
cap
ed
provid
collect
blood
cultur
administ
antibiot
sputum
cultur
applic
although
case
etiolog
test
reveal
caus
pathogen
care
sever
assess
crucial
step
ed
cap
manag
includ
screen
occult
sepsi
serum
lactat
follow
earli
antibiot
fluid
resuscit
indic
risk
stratif
tool
psi
use
routin
determin
appropri
disposit
patient
emerg
provid
familiar
latest
guidelin
antimicrobi
treatment
outpati
inpati
cap
continu
chang
resist
pattern
respiratori
pathogen
evolv
vaccin
must
encourag
continu
prevent
respiratori
infect
children
adult
